DeYoung Sullivan Karen, Vu Truc, Richardson Goley, Castillo Estella, Martinez Fernando
University of Texas MD Anderson Cancer Center in Houston.
Clin J Oncol Nurs. 2015 Oct;19(5):516-20. doi: 10.1188/15.CJON.516-520.
Patients with cancer are often dependent on blood transfusions during treatment. Frequent vital sign monitoring during transfusions may interrupt sleep and the patient's ability to ambulate or participate in unit activities. Relying heavily on vital sign findings may also overshadow unmeasurable symptoms of transfusion reaction. The aim of this evidence-based practice initiative was to examine the evidence regarding the optimum frequency of vital sign monitoring for patients undergoing stem cell transplantation receiving blood products and to amend policy and practice to be consistent with the literature. AT A GLANCE : Patients with cancer frequently require transfusion support during treatment.Inconsistencies exist in recommendations for the frequency of vital sign monitoring during transfusion.Examining best practice guidelines suggests that less frequent vital sign monitoring may be appropriate if coupled with thoughtful physiologic assessment.
癌症患者在治疗期间常常依赖输血。输血过程中频繁的生命体征监测可能会干扰睡眠以及患者的活动能力或参与病房活动的能力。过度依赖生命体征检查结果也可能会掩盖输血反应中一些无法测量的症状。这项基于循证实践的倡议旨在研究关于接受血液制品的干细胞移植患者生命体征监测最佳频率的证据，并修订政策和实践以使其与文献保持一致。
癌症患者在治疗期间经常需要输血支持。关于输血期间生命体征监测频率的建议存在不一致之处。对最佳实践指南的研究表明，如果结合细致的生理评估，减少生命体征监测的频率可能是合适的。
